EUCTR2005-001228-35-GB进行中(未招募)不适用
A randomized, single-blind, parallel-group, multi-center comparative study to assess the efficacy and safety of an application of Fybex (fibrin sealant) to the operative field, for the reduction of post-operative blood loss, when added to standard intra-operative hemostatic procedures and compared to standard intra-operative hemostatic procedures alone, in adult patients undergoing total hip arthroplasty - A study to assess the effect of Fybex fibrin sealant on post-operative blood loss, given during hip
Bio Products Laboratory0 个研究点目标入组 90 人开始时间: 2005年9月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •·Patients undergoing total hip replacement·Age > 18 years·Able to give informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •·History of bleeding disorders·Hb < 110g/L·Previous hip surgery·Use of other blood products within 3 months·Positive for HBsAg, HCV or HIV
研究者
相似试验
进行中(未招募)
不适用
A study comparing the efficacy and safety of LA-EP2006 and Neulasta in breast cancer patients being treated with types of chemotherapy which decrease white blood cells.Breast CancerEUCTR2011-004532-58-BGSandoz GmbH302
进行中(未招募)
1 期
A randomized, double-blind, parallel-group, multi-center Phase III studycomparing the efficacy and safety of EP2006 and Neupogen® in breastcancer patients treated with myelosuppressive chemotherapyMedDRA version: 15.0Level: LLTClassification code 10006203Term: Breast cancer stage unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Breast cancerEUCTR2010-024481-22-HUSandoz GmbH
进行中(未招募)
不适用
A study comparing the efficacy and safety of EP2006 and Neupogen® in breast cancer patients being treated with types of chemotherapy which decrease white blood cellsMedDRA version: 14.1Level: LLTClassification code 10006203Term: Breast cancer stage unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Breast cancerEUCTR2010-024481-22-LVSandoz GmbH192
进行中(未招募)
不适用
A study comparing the efficacy and safety of EP2006 and Neupogen® inbreast cancer patients being treated with types of chemotherapy whichdecrease white blood cellsMedDRA version: 14.1Level: LLTClassification code 10006203Term: Breast cancer stage unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Breast cancerEUCTR2010-024481-22-CZSandoz GmbH192
进行中(未招募)
不适用
A study comparing the efficacy and safety of EP2006 and Neupogen® inbreast cancer patients being treated with types of chemotherapy whichdecrease white blood cellsMedDRA version: 14.0Level: LLTClassification code 10006203Term: Breast cancer stage unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Breast cancerEUCTR2010-024481-22-SKSandoz GmbH192
